- Home
- IMMX vs BIRD Comparison
IMMX vs BIRD Comparison
Compare IMMX & BIRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- BIRD
- Stock Information
- Founded
- IMMX 2014
- BIRD 2015
- Country
- IMMX United States
- BIRD United States
- Employees
- IMMX N/A
- BIRD N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- BIRD Apparel
- Sector
- IMMX Health Care
- BIRD Consumer Discretionary
- Exchange
- IMMX Nasdaq
- BIRD Nasdaq
- Market Cap
- IMMX 82.6M
- BIRD 89.7M
- IPO Year
- IMMX 2021
- BIRD 2021
- Fundamental
- Price
- IMMX $3.28
- BIRD $6.09
- Analyst Decision
- IMMX Strong Buy
- BIRD Buy
- Analyst Count
- IMMX 1
- BIRD 2
- Target Price
- IMMX $8.00
- BIRD $11.00
- AVG Volume (30 Days)
- IMMX 769.8K
- BIRD 83.5K
- Earning Date
- IMMX 11-07-2025
- BIRD 11-06-2025
- Dividend Yield
- IMMX N/A
- BIRD N/A
- EPS Growth
- IMMX N/A
- BIRD N/A
- EPS
- IMMX N/A
- BIRD N/A
- Revenue
- IMMX N/A
- BIRD $160,639,000.00
- Revenue This Year
- IMMX N/A
- BIRD N/A
- Revenue Next Year
- IMMX N/A
- BIRD $4.65
- P/E Ratio
- IMMX N/A
- BIRD N/A
- Revenue Growth
- IMMX N/A
- BIRD N/A
- 52 Week Low
- IMMX $1.34
- BIRD $3.93
- 52 Week High
- IMMX $4.05
- BIRD $12.85
- Technical
- Relative Strength Index (RSI)
- IMMX 55.27
- BIRD 39.91
- Support Level
- IMMX $2.85
- BIRD $5.90
- Resistance Level
- IMMX $3.53
- BIRD $9.19
- Average True Range (ATR)
- IMMX 0.38
- BIRD 0.70
- MACD
- IMMX -0.07
- BIRD -0.22
- Stochastic Oscillator
- IMMX 34.80
- BIRD 3.80
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About BIRD Allbirds Inc.
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.